Overall Response to Anti-IL-5/Anti-IL5-Rα Treatment in Severe Asthma Does Not Depend on Initial Bronchodilator Responsiveness-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Overall Response to Anti-IL-5/Anti-IL5-Rα Treatment in Severe Asthma Does Not Depend on Initial Bronchodilator Responsiveness

Published:2022-12 Issue:12 Volume:10 Page:3174-3183
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Mümmler Carlo,Suhling Hendrik,Walter Julia,Kneidinger Nikolaus,Buhl Roland,Kayser Moritz Z.,Drick Nora,Behr Jürgen,Welte Tobias,Korn Stephanie,Milger Katrin^ORCID

Funder

Sanofi

GlaxoSmithKline

Bundesministerium für Bildung und Forschung

Teva Pharmaceutical Industries

Novartis

Chiesi Farmaceutici

Boehringer Ingelheim

AstraZeneca

Novartis Pharma

Roche

Sanofi-Aventis Deutschland

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference30 articles.

1. Standardization of spirometry 2019 update. An Official American Thoracic Society and European Respiratory Society Technical Statement;Graham;Am J Respir Crit Care Med,2019

2. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma;Chung;Eur Respir J,2014

3. Low-dose oral corticosteroids in asthma associates with increased morbidity and mortality;Skov;Eur Respir J,2022

4. Effective management of severe asthma with biologic medications in adult patients: a literature review and international expert opinion;Buhl;J Allergy Clin Immunol Pract,2022

5. Oral glucocorticoid–sparing effect of benralizumab in severe asthma;Nair;N Engl J Med,2017

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bronchodilator Responsiveness in Asthma and Chronic Obstructive Pulmonary Disease: Time to Stop Chasing Shadows;American Journal of Respiratory and Critical Care Medicine;2024-02-15

2. Lung function trajectories in a cohort of patients with moderate‐to‐severe asthma on mepolizumab, omalizumab, or dupilumab;Allergy;2024-01-02

3. Role of Long-Acting Bronchodilators in Patients with Clinical Asthma Remission;Respiration;2024

4. Biologics for severe asthma and beyond;Pharmacology & Therapeutics;2023-12

5. Characterization of Austrian severe asthma patients;Respiratory Medicine;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3